These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 28915843)
1. Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats. Ullah A; Jahan S; Razak S; Pirzada M; Ullah H; Almajwal A; Rauf N; Afsar T J Ovarian Res; 2017 Sep; 10(1):62. PubMed ID: 28915843 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of melatonin against metabolic and reproductive disturbances in polycystic ovary syndrome in rats. Pai SA; Majumdar AS J Pharm Pharmacol; 2014 Dec; 66(12):1710-21. PubMed ID: 25176048 [TBL] [Abstract][Full Text] [Related]
3. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome. Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098 [TBL] [Abstract][Full Text] [Related]
4. Mechanistic links between oxidative/nitrosative stress and tumor necrosis factor alpha in letrozole-induced murine polycystic ovary: biochemical and pathological evidences for beneficial effect of pioglitazone. Rezvanfar MA; Rezvanfar MA; Ahmadi A; Saadi HA; Baeeri M; Abdollahi M Hum Exp Toxicol; 2012 Sep; 31(9):887-97. PubMed ID: 22076494 [TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism. Rajan RK; M SS; Balaji B Pharm Biol; 2017 Dec; 55(1):242-251. PubMed ID: 27927075 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic potentials of Quercetin in management of polycystic ovarian syndrome using Letrozole induced rat model: a histological and a biochemical study. Jahan S; Abid A; Khalid S; Afsar T; Qurat-Ul-Ain ; Shaheen G; Almajwal A; Razak S J Ovarian Res; 2018 Apr; 11(1):26. PubMed ID: 29615083 [TBL] [Abstract][Full Text] [Related]
7. Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats. Jahan S; Munir F; Razak S; Mehboob A; Ain QU; Ullah H; Afsar T; Shaheen G; Almajwal A J Ovarian Res; 2016 Dec; 9(1):86. PubMed ID: 27923406 [TBL] [Abstract][Full Text] [Related]
9. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS. Ryan GE; Malik S; Mellon PL Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436 [TBL] [Abstract][Full Text] [Related]
10. [Study on the oxidative stress in the ovaries of a rat model of polycystic ovary]. Gong J; Wu DB; Zhang LL; Li J; Zhao X; Zhang D Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 Mar; 46(2):238-42, 247. PubMed ID: 25924437 [TBL] [Abstract][Full Text] [Related]
11. The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome. Hong Y; Yin Y; Tan Y; Hong K; Zhou H Med Sci Monit; 2019 Jan; 25():395-401. PubMed ID: 30636259 [TBL] [Abstract][Full Text] [Related]
12. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin. Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of sodium selenite in letrozole induced polycystic ovary syndrome rat model: Targeting mitochondrial approach (selenium in PCOS). Atef MM; Abd-Ellatif RN; Emam MN; Abo El Gheit RE; Amer AI; Hafez YM Arch Biochem Biophys; 2019 Aug; 671():245-254. PubMed ID: 31251923 [TBL] [Abstract][Full Text] [Related]
14. Thuja occidentalis L. and its active compound, α-thujone: Promising effects in the treatment of polycystic ovary syndrome without inducing osteoporosis. Küpeli Akkol E; İlhan M; Ayşe Demirel M; Keleş H; Tümen I; Süntar İ J Ethnopharmacol; 2015 Jun; 168():25-30. PubMed ID: 25818694 [TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of a novel selenium-based complementary medicine which confers protection against hyperandrogenism-induced polycystic ovary. Rezvanfar MA; Rezvanfar MA; Ahmadi A; Shojaei-Saadi HA; Baeeri M; Abdollahi M Theriogenology; 2012 Aug; 78(3):620-31. PubMed ID: 22541319 [TBL] [Abstract][Full Text] [Related]
17. A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Mannerås L; Cajander S; Holmäng A; Seleskovic Z; Lystig T; Lönn M; Stener-Victorin E Endocrinology; 2007 Aug; 148(8):3781-91. PubMed ID: 17495003 [TBL] [Abstract][Full Text] [Related]
18. Pioglitazone is effective for multiple phenotyepes of the Zucker fa/fa rat with polycystc ovary morphology and insulin resistance. Morishita M; Endo T; Baba T; Kuno Y; Ikeda K; Kiya T; Honnma H; Saito T J Ovarian Res; 2018 Mar; 11(1):24. PubMed ID: 29580285 [TBL] [Abstract][Full Text] [Related]